Recently, the innovative product "Vflower® Venous Stent System" of Shanghai Bluevastec MedTech Co., Ltd. is approved by China NMPA.

This product consists of a venous stent and a delivery system, intended for use in the iliofemoral veins for the treatment of non-thrombotic iliac vein compression syndrome, deep vein thrombosis and post deep vein thrombosis syndrome. The stent is manufactured using an integrated braiding method, featuring varying mesh densities. The combination of dense and sparse mesh designs effectively meets clinical needs for both support and flexibility.

The NMPA will strengthen the post-marketing surveillance of the product to protect the safety of medical devices used by patients.